The results generated in H1 2021 by MedApp S.A. are similar to the results the Company achieved for the whole of 2020. The interview with Krzysztof Mędrala, CEO of MedApp S.A.

26 August 2021

The results generated in H1 2021 by MedApp S.A. are similar to the results the Company achieved for the whole of 2020. The interview with Krzysztof Mędrala, CEO of MedApp S.A.

In connection with the publication of the Interim Report for Q2 2021 on September 12, 2021, we invite you to watch the interview with Krzysztof Mędrala, CEO of MedApp S.A. according to Company’s activities realized in the reporting period and the financial results achieved in H1 2021.

If you have any investor questions, feel free to send them to biuro@medapp.pl!

Read more See similar articles:

19 September 2024

Panel discussion as part of Krynica Forum 2024 with MedApp participation.

The panel discussion within Krynica Forum 2024 “European Entrepreneurial Region: how do Malopolska’s start-ups implement the innovative solutions of the future?” with the participation of Maciej Stanuch, CarnaLife Holo Technology Manager at MedApp S.A., is behind us.

17 September 2024

CarnaLife Holo mixed reality 3D holographic imaging technology joins another hospital.

Doctors at the Bieganski Hospital in Lodz, Poland keep up with the times by using the latest medical technology to help patients. By using our software, doctors can better interpret patients’ diagnostic imaging data, which significantly contributes to improving the quality of treatment and reducing treatment time.

13 September 2024

CarnaLife Holo’s real-time holographic cardiac echo imaging has been featured in the U.S. portal Cardiovascular Business.

A few months after receiving FDA certification, CarnaLife Holo has been spotlighted by the opinionated industry portal CardiovascularBusiness.com